artificial intelligence
The future of artificial intelligence.
Exploring the Vast Universe of Perry Rhodan
I first stumbled upon Perry Rhodan on a rainy Saturday afternoon in a tiny secondhand bookstore in Berlin. I wasn’t looking for it—I was just hiding from the cold—but the neon orange spines on the shelf called to me like a secret. I picked up the first issue and found myself staring at a cover depicting gleaming spaceships, alien landscapes, and a man who somehow looked both heroic and terrified.
By John Smith16 days ago in Futurism
Europe In Vitro Diagnostics Market Set to Reach USD 49.49 Billion by 2031. AI-Generated.
The Europe in vitro diagnostics (IVD) market is entering a decisive growth phase as healthcare systems, policymakers, and life sciences leaders intensify investments in early detection, automation, and precision medicine. Valued at USD 31.43 billion in 2025 and USD 33.83 billion in 2026, the market is projected to expand at a resilient CAGR of 7.9% from 2026 to 2031, reaching USD 49.49 billion by the end of the forecast period.
By Jennifer Reynolds16 days ago in Futurism
US Injectable Drug Delivery Market Set to Reach USD 465.15 Billion by 2031. AI-Generated.
The US injectable drug delivery market is entering a decisive growth phase as biologics, long-acting therapies, and patient-centric self-administration systems reshape how advanced medicines are developed, manufactured, and delivered. Valued at USD 285.81 billion in 2025 and USD 309.90 billion in 2026, the market is projected to reach USD 465.15 billion by 2031, expanding at a resilient CAGR of 8.5%.
By Jennifer Reynolds16 days ago in Futurism
U.S. AI in Healthcare Market Set to Surge to USD 43.30 Billion by 2030. AI-Generated.
The U.S. artificial intelligence (AI) in healthcare market is entering a decisive expansion phase, driven by structural workforce shortages, escalating operational complexity, and urgent demand for automation and clinical precision. Valued at USD 5.98 billion in 2024 and USD 8.65 billion in 2025, the market is projected to grow at a resilient CAGR of 38.0% from 2025 to 2030, reaching USD 43.30 billion by the end of the forecast period.
By Jennifer Reynolds16 days ago in Futurism
Asia Pacific Telehealth & Telemedicine Market Set to Surpass USD 40.8 Billion by 2030. AI-Generated.
The Asia Pacific telehealth and telemedicine market is entering a decisive growth phase, positioning digital healthcare as a core pillar of regional health system modernization and enterprise healthcare strategy.
By Jennifer Reynolds16 days ago in Futurism
Europe Telehealth & Telemedicine Market on Track to Exceed US$42 Billion by 2030. AI-Generated.
The Europe telehealth and telemedicine market is transitioning from rapid adoption to structural integration within national healthcare systems and enterprise health strategies. Valued at US$22.01 billion in 2024 and US$24.76 billion in 2025, the market is projected to reach US$42.04 billion by 2030, expanding at a resilient CAGR of 11.2% from 2025 to 2030.
By Jennifer Reynolds16 days ago in Futurism
Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030. AI-Generated.
The global ophthalmology drugs market, valued at US$18.34 billion in 2024, stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$26.28 billion by the end of the period. This growth trajectory reflects a convergence of demographic shifts, scientific breakthroughs, and strategic industry initiatives that are redefining the competitive landscape.
By Juan Martinez16 days ago in Futurism
Global Wound Care Market Set to Surpass USD 30.48 Billion by 2030. AI-Generated.
The global wound care market, valued at US$20.97 billion in 2024, stood at US$22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$30.48 billion by the end of the period. This growth is propelled by an upsurge in traumatic and burn injuries, the increasing prevalence of chronic diseases, and the swelling ranks of the geriatric population. Governments and healthcare providers are also driving adoption through supportive reimbursement frameworks, while new technologies are redefining care delivery.
By Juan Martinez16 days ago in Futurism




